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ABSTRACT
Several published protocols exist for isolating contractile or myofibrillar (MF) proteins from skeletal muscle, however, 
achieving complete resuspension of the myofibril pellet can be technically challenging. We performed several previously 
published MF isolation methods with the intent of determining which method was most suitable for MF protein isolation 
and solubilization. Here, we provide an optimized protocol to isolate sarcoplasmic and solubilized MF protein fractions 
from mammalian skeletal muscle suitable for several downstream assays.
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INTRODUCTION
Several researchers have had an interest in isolating and solubilizing 
skeletal muscle myofibrillar (MF) proteins to assess MF protein synthesis 
rates [1-12], or chronic changes in myofibril protein concentrations in 
response to exercise training [13-21]. However, isolating and solubiliz-
ing MF proteins is technically challenging given that skeletal muscle is 
made up of ~80% MF protein (on a dry mass basis) [22], and contractile 
proteins possess large molecular masses and are highly interconnected. 
Different methods for MF protein isolation and quantification have been 
published. For instance, some studies have used the phenol phase from 
the guanidinium thiocyanate-phenol-chloroform extraction method 
(TRIzol) to extrapolate vastus lateralis (VL) MF protein changes both 
acutely [14] and following long-term resistance training [16]. Likewise, 
we recently examined how 12 weeks of resistance training affected 
VL MF and sarcoplasmic protein concentrations in college-aged male 
subjects [13] by utilizing a protocol from Goldberg’s laboratory [23] 
(referred to herein as MF method 1). This method isolates sarcoplasmic 
and MF proteins, and our analyses confirmed that prominent myosin 
and actin bands were present through SDS-PAGE and Coomassie 
imaging of the isolated MF protein fraction [13]. However, as noted 
above, myofibril pellet solubility in the final resuspension solution was 
relatively poor and required continuous manual disaggregation. Beyond 
these two aforementioned methods, several tracer studies examining 
the fractional synthetic rate of VL MF protein have allocated a meth-
od similar to Goldberg’s for the separation of MF and sarcoplasmic 
constituents followed by the solubilization of the MF protein pellet 
through the addition of 0.3 M NaOH and heating/vortexing [18,24-26]. 
Several laboratories also use commercially-made RIPA or general cell 
lysis buffers to process muscle tissue for downstream assays such as 
Western blotting. However, based on our extensive experience, these 
buffers typically leave behind a large protein pellet following homog-
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enization and centrifugation, and much of this residual protein pellet 
likely contains MF proteins.
While numerous methods for MF protein isolation have been reported 
throughout the literature, no study has thoroughly investigated if these 
methods yield similar protein concentrations and protein integrity. 
Comparing and contrasting these methods and determining which 
method yields optimal results (i.e., completely solubilized myofibrils) 
are imperative given that several different methods for muscle tissue 
homogenizing exist. Therefore, the purpose of this study was to compare 
the five different protein isolation methods with respect to MF protein 
yield and integrity (Experiment 1). Additionally, we leveraged results 
from Experiment 1 to develop an optimized and proteomic-validated 
procedure, which we have coined as the “myofibril isolation and solu-
bilization technique” or “MIST”, that can be allocated to isolate soluble 
MF and sarcoplasmic protein fractions (Experiment 2).
MATERIALS AND METHODS
Ethical approval for rodent study and gastrocnemius 
dissections
Due to the relatively large tissue requirement needed for Experiment 1, 
rat gastrocnemius muscle was analyzed. Gastrocnemius muscles were 
obtained from three 6-month old and three 18-month old male Fisher 
rats in a protocol which was previously approved by the Auburn Uni-
versity Animal Care and Use Committee. The sampling of this muscle 
from younger and older male rats was due to convenience given that we 
had a plentiful amount of muscle left over from previously published 
studies [27,28]. It should be noted that the purpose of this study was 
not to perform age comparisons for outcome variables. Rather, we 
were primarily interested in determining which method was optimal 
for isolating and solubilizing MF protein. Readers are encouraged to 
refer to [27] for further experimental details regarding animal husbandry 
and tissue procurement.
Ethical approval for obtaining human muscle
Prior to engaging in data collection, the human portion of this study 
was approved by the Institutional Review Board at Auburn University 
(Protocol # 18-442 MR 1812) and conformed to the standards set by 
the latest revision of the Declaration of Helsinki. College-aged males 
from the local community were recruited to participate in this study. 
Participants provided both verbal and written informed consent, and 
completed a medical history form prior to screening.
Muscle biopsies were collected using a 5-gauge needle under local 
anesthesia as previously described [29]. Immediately following tissue 
procurement, ~100 mg of tissue was teased of blood and connective 
tissue, wrapped in pre-labelled foils, flash frozen in liquid nitrogen, and 
subsequently stored at −80°C until assays described below.
Experiment 1 procedures
On the day of homogenization, muscles were powdered on a liquid 
nitrogen-cooled ceramic mortar and pestle. Frozen tissue (20–25 mg) 
from the six rats was weighed from each muscle using an analytical 
scale with a sensitivity of 0.0001 g (Mettler-Toledo; Columbus, OH, 
USA) and quickly placed in the first buffer of the five methods listed 
below. For all methods except the general cell lysis (GCL) method we 
began protocols with ~20 mg muscle and 200 µl of buffer 1, and re-
suspended the MF pellet from all methods in 300 µl of the final buffer. 
The GCL method, however, is a one-step method; thus, ~20 mg muscle 
was added to 300 µl of GCL buffer described below. The remainder of 
this section discusses the five protocols used for comparative analyses.
Trizol method: Approximately 20 mg of muscle from each rat were 
placed in 1.7 ml tubes containing 200 µl of Trizol (Ribozol; Ameresco, 
Solon, OH, USA; Cat. # N580), manually homogenized using a tight-fit-
ting microtube pestle, and allowed to incubate at room temperature for 
10 min. During the muscle crushing procedure, pestles were visually 
inspected with rigor to ensure no residual tissue remained on the pestle 
as it was being removed from the 1.7 ml tubes. Notably, residual tissue 
on the pestle would result in a loss of protein and an underestimation of 
protein content when normalized to input muscle weights. Chloroform 
(40 µl; Ameresco) was then added to tubes, and tubes were vigorously 
shaken for 15 s and incubated at room temperature for 3 min. Tubes 
were then centrifuged at 12000 g for 15 min at 4°C. The resultant clear 
supernatant (containing RNA) was completely removed, 60 µl of 100% 
ethanol (Ameresco) was added to tubes which contained the inter- and 
organic phases, and tubes were vigorously shaken for 15 s and incubated 
at room temperature for 3 min. Tubes were centrifuged at 2000 g for 
5 min at 4°C, and phenol/ethanol supernatants (containing protein) 
were transferred to new 1.7 ml tubes. Isopropanol (300 µl; Ameresco) 
was added to the phenol/ethanol fraction, and tubes were vigorously 
shaken for 15 s and incubated at room temperature for 10 min. Tubes 
were centrifuged at 12000 g for 10 min at 4°C, the supernatant was 
discarded, and the protein pellet was dried in a lyophilizing apparatus for 
5 min. The protein pellet was then resuspended in 300 µl of 1% sodium 
dodecyl sulfate solution (w/v in deionized water; Ameresco) using a 
tight-fitting micropestle. Tubes were then centrifuged at 10000 g for 10 
min at 4°C to remove insoluble material, and the final supernatant was 
transferred to a new 1.7 ml microtube and stored at −80°C for protein 
analyses described below. Notably, no putative sarcoplasmic fraction 
was yielded from this procedure, and 1% SDS was largely ineffective 
at solubilizing the protein pellet.
General cell lysis method: Approximately 20 mg of muscle from 
each rat was placed in 1.7 ml tubes containing 300 µl of ice-cold 
pre-fabricated 1× general cell lysis buffer (20 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM 
sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1 µg/ml 
leupeptin; Cell Signaling, Danvers, MA, USA). Samples were homog-
enized using tight-fitting pestles, insoluble proteins were removed with 
centrifugation at 500 g for 5 min, and supernatants were transferred to 
a new 1.7 ml tube and stored at −80°C for protein analyses described 
below. Again, pestles were visually inspected with rigor to ensure that 
no residual tissue remained on the pestle as it was being removed from 
the 1.7 ml tubes. As with the Trizol method, no sarcoplasmic fraction 
was yielded from this procedure.
MF method 1: Approximately 20 mg of muscle from each rat was 
placed in 1.7 ml tubes containing 200 μl of ice cold homogenizing buffer 
(buffer 1: 20 mM Tris-HCl, pH 7.2, 5 mM EGTA, 100 mM KCl, 1% 
Triton-X100; all chemicals from Ameresco). Samples were homoge-
nized using tight-fitting pestles and centrifuged at 3000 g for 30 min at 
4°C. Again, pestles were visually inspected with rigor to ensure that no 
residual tissue remained on the pestle as it was being removed from the 
1.7 ml tubes. Supernatants (sarcoplasmic fraction) were transferred to 
new 1.7 ml tubes and stored at −80°C until protein analyses described 
below. As a wash step, resultant pellets (MF fraction) were resuspended 
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in buffer 1, and samples were centrifuged at 3000 g for 10 min at 4°C. 
Resultant supernatants from this step were discarded, pellets were 
resuspended in 200 μl of ice cold wash buffer (buffer 2: 20 mM Tris-
HCl, pH 7.2, 100 mM KCl, 1 mM DTT; all chemicals from Ameresco), 
and tubes were centrifuged at 3000 g for 10 min at 4°C; this step was 
performed twice. Final myofibril pellets were resuspended in 300 μl 
of ice cold storage buffer (buffer 3: 20 mM Tris-HCl, pH 7.2, 100 mM 
KCl, 20% glycerol, 1 mM DTT; all chemicals from Ameresco), and 
stored at −80°C for protein analyses described below.
MF method 2: We sought to improve MF method 1 given that this 
method yields insoluble MF aggregates when the pellet is resuspend-
ed in the final resuspension buffer (buffer 3). Others have previously 
demonstrated that the addition of the polyamine spermidine increases 
protein solubility during tissue processing [30]. Notwithstanding, it 
remained to be determined if modifying MF method 1 through the 
addition of spermidine in the final resuspension solution (buffer 3) 
would further increase MF protein solubility and, ultimately, protein 
yield. Procedures for MF method 2 were identical to MF method 1 
except that MF pellets were resuspended in 300 μl of ice cold storage 
buffer as described above (buffer 3: 20 mM Tris-HCl, pH 7.2, 100 mM 
KCl, 20% glycerol, 1 mM DTT; all chemicals from Ameresco) with the 
addition of 6.4 M spermidine (Alfa Aesar, Haverhill, MA USA) to yield 
a working concentration of 50 mM spermidine in Buffer 3.
MF method 3: Approximately 20 mg of muscle from each rat was 
placed in 1.7 ml tubes containing 200 μl ice-cold buffer (buffer 1: 25 
mM Tris, pH 7.2, 0.5% Triton X-100; all chemicals from Ameresco). 
Samples were homogenized using tight-fitting pestles and centrifuged 
at 1500 g for 10 min at 4°C. Again, pestles were visually inspected 
with rigor to ensure that no residual tissue remained on the pestle as it 
was being removed from the 1.7 ml tubes. Supernatants (sarcoplasmic 
fraction) were transferred to new 1.7 ml tubes, and stored at −80°C 
until protein analyses described below. As a wash step, resultant MF 
pellets were resuspended in buffer 1, and centrifuged at 1500 g for 10 
min at 4°C. Supernatants were discarded, MF pellets were solubilized 
in 300 μl NaOH (0.3 M; Ameresco), and tubes were heated to 50°C 
for 30 min with vortex mixing every 10 min. Tubes were centrifuged 
at 4000 g for 5 min at 4°C, the supernatant containing the MF fraction 
was collected, placed in new 1.7 ml tubes, and stored at −80°C until 
protein analyses described below. Notably, while others have reported 
that insoluble collagen pellets remain after this step [25], we did not 
observe such pellets.
Protein concentration determination
Protein concentrations of sarcoplasmic isolates (when applicable) 
as well as putative MF resuspensions were quantified using the bicin-
choninic acid (BCA) colorimetric assay (Thermo Scientific, Waltham, 
MA, USA). First, samples were diluted 5-fold with distilled water prior 
to assaying. Each diluted sample (20 µl) and bovine serum albumin 
(BSA) standards ranging from 0.125–2 µg/µl (20 µl) were loaded in 
triplicate wells on clear polystyrene 96-well microplates. Blank buffers 
from each isolation method (20 µl) were also loaded in triplicate wells 
for background subtraction. BCA reagent (200 µl) was added to all 
wells, and plates were incubated on an orbital plate shaker at 500 rpm 
for ~60 min at room temperature. The microplate was then read at an 
absorbance of 590 nm using a spectrophotometer (BioTek Synergy 
H1; BioTek Instruments, Inc., Winooski, VT USA). Accompanying 
software was used for analysis where standard curves were generated, 
buffer-only absorbance values were subtracted from each respective 
sample, and final protein concentrations were calculated back to the 
standard curve after being corrected for the 5× dilution factor. For total 
MF protein yield, final protein concentrations were multiplied by 300 
(i.e., the total volume of buffer used to resuspend the MF pellet). These 
values were then divided by input wet muscle weights to yield µg MF 
protein per mg wet muscle. Sarcoplasmic fractions from MF method 1 
were not quantified given that the steps were identical in obtaining this 
fraction between MF methods 1 and 2.
SDS-PAGE and Coomassie staining for Experiment 1
SDS-PAGE sample preps from MF protein resuspensions were 
prepared using: 10 μl resuspensions from each method + 65 μl distilled 
water + 25 μl 4× Laemmli buffer. Sample preps (5 μl) were then loaded 
on pre-casted gradient (4%–15%) SDS-polyacrylamide gels (Bio-Rad 
Laboratories, Hercules, CA USA) and subjected to electrophoresis at 
200 V for 40 min using pre-made 1× SDS-PAGE buffer (Ameresco). 
Gels were rinsed in distilled water for 15 min following electrophoresis, 
and immersed in Coomassie stain (LabSafe GEL Blue; G-Biosciences; 
St. Louis, MO, USA) for 60 min. Thereafter, gels were destained in 
tap water for 60 min, bright field imaged using a gel documentation 
system (UVP; Upland, CA, USA), and band densities were determined 
using associated software. Given that the same volume per sample was 
loaded for SDS-PAGE, resultant myosin and actin band densities were 
divided by input muscle weights and expressed as arbitrary density 
units (ADU)/mg wet muscle.
Western blotting
Western blotting for myosin and actin detection was performed using 
an anti-myosin antibody against all myosin isoforms (DSHB, Iowa 
City, IA, USA; Cat. # A4.1025) and an anti-actin antibody against actin 
(α-sarcomeric) (Sigma-Aldrich, Saint Louis, MO, USA; Cat. # A2172), 
respectively, per the methods of Zergeroglu et al. [31]. Briefly, SDS-
PAGE was performed on SDS-PAGE sample preps from MF protein 
resuspensions, and proteins were transferred to polyvinylidene difluoride 
membranes at 200 mA for 2 h (Bio-Rad Laboratories). Membranes 
were then blocked for 60 min at room temperature with 5% nonfat milk 
powder in Tris-buffered saline with 0.1% Tween-20 (TBST; Ameres-
co). Membranes were then incubated with myosin and actin antibody 
solutions (1:5000 dilution of each stock antibody in TBST with 5% 
BSA) overnight at 4°C. The following day, membranes were washed 
in TBST and incubated with horseradish peroxidase (HRP)-conjugated 
anti-rabbit IgG (Cat. # 7074; Cell Signaling; Danvers, MA, USA) or 
HRP-conjugated anti-mouse IgG (Cat. # 7072; Cell Signaling) in TBST 
with 5% BSA (1:2000) at room temperature for 60 min. Membrane 
development was performed using an enhanced chemiluminescent re-
agent (Luminata Forte HRP substrate; EMD Millipore, Billerica, MA, 
USA), and digital images were captured using a gel documentation 
system (UVP, Cambridge, UK).
Experiment 2: development of an optimized procedure 
from Experiment 1 results
Experiment 1 indicated that the sarcoplasmic isolation from MF 
method 3 and the MF isolation from MF method 2 yielded the highest 
fidelity fractions. Thus, in Experiment 2 we sought to determine if an 
optimized procedure which combined both methods could be applied 
to human skeletal muscle to isolate high fidelity sarcoplasmic and MF 
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proteins. Briefly, skeletal muscle from six human subjects (~20 mg) 
were placed in 1.7 ml tubes containing 200 μl ice-cold buffer (buffer 1 
from MF method 3: 25 mM Tris, pH 7.2, 0.5% Triton X-100). Tubes 
were homogenized using tight-fitting pestles and centrifuged at 1500 g 
for 10 min at 4°C. Supernatants (sarcoplasmic fraction) were collect-
ed, transferred to new 1.7 ml tubes, and stored at −80°C until BCA 
and proteomic assays. As a wash step, the resultant MF pellet was 
resuspended in buffer 1, and centrifuged at 1500 g for 10 min at 4°C. 
The supernatant was discarded, and the MF pellet was solubilized in 
300 μl of ice cold storage buffer (buffer 3 from MF method 2:20 mM 
Tris-HCl, pH 7.2, 100 mM KCl, 20% glycerol, 1 mM DTT, 50 µM 
spermidine). The solubilized MF pellet was then stored at −80°C until 
BCA and proteomic assays.
Protein quantification of each fraction obtained from human muscle 
occurred as described above. Shotgun proteomics was also performed at 
Florida State University (Tallahassee, FL, USA) on the sarcoplasmic and 
MF protein fractions to identify enriched proteins in each fraction, and 
then determine if there was significant contamination of these proteins 
in each opposing fraction. Each protein sample for triplicate technical 
runs (30 µg for each run) was prepared for LC-MS/MS analysis using 
EasyPep Mini MS Sample Prep Kit (Thermo Scientific). Protein sample 
was transferred into a new microcentrifuge tube and the final volume 
was adjusted to 100 µl with general cell lysis buffer (Cell Signaling). 
Reduction alkylation solutions (50 µl each) were added to samples, 
gently mixed, and incubated at 95°C using heat block for 10 min to 
reduce and alkylate samples, respectively. After incubation, samples 
were removed and cooled to room temperature. The reconstituted enzyme 
Trypsin/Lys-C Protease Mix solution (50 µl) was added to the reduced and 
alkylated samples and incubated with shaking at 37°C for 2 h to digest 
the protein sample. Digestion stop solution (50 µl) was then added to 
samples, and peptides were cleaned using a peptide clean-up column 
according to the kit instructions.
An externally calibrated Thermo Q Exactive HF (high-resolution 
electrospray tandem mass spectrometer) was used in conjunction with 
Dionex UltiMate3000 RSLC Nano System (Thermo Scientific). Sample 
(5 µl) was aspirated into a 50 µl loop and loaded onto the trap column 
(Thermo µ-Precolumn 5 mm, with nanoViper tubing 30 µm i.d. × 10 
cm). Flow rate was set to 300 NL/min for separation on the analytical 
column (Acclaim pepmap RSLC 75 µM × 15 cm nanoviper; Thermo 
Scientific). Mobile phase A was composed of 99.9% H2O (EMD Omni 
Solvent; Millipore, Austin, TX, USA) and 0.1% formic acid, and mobile 
phase B was composed of 99.9% acetonitrile and 0.1% formic acid. A 
60-minute linear gradient from 3% to 45% B was performed. The LC 
eluent was directly nanosprayed into the mass-spectrometer. During 
chromatographic separation, the Q-Exactive HF was operated in a 
data-dependent mode and under direct control of the Thermo Excalibur 
3.1.66 (Thermo Scientific). MS data were acquired using the following 
parameters: 20 data-dependent collisional-induced-dissociation MS/
MS scans per full scan (350 to 1700 m/z) at 60000 resolution. MS2 
data were acquired in centroid mode at 15000 resolution. Ions with 
a single charge or charges more than 7 as well as unassigned charge 
were excluded. A 15-second dynamic exclusion window was used. All 
measurements were performed at room temperature, and three technical 
replicates were performed for each sample. Raw data files were ana-
lyzed using the Proteome Discoverer software package (version 2.0, 
Thermo Scientific) with SequestHT and Mascot search nodes using a 
human-specific tremble .fasta database (20180308HumanSwissprot.
fasta) and the Percolator peptide validator. The resulting .msf files 
were further analyzed by the proteome validator software Scaffold 
v4.0 (Portland, OR, USA).
Statistics
One-way analysis of variance (ANOVA) tests were used to examine 
dependent variables in Experiment 1. If P values reached a threshold 
for significance (P < 0.05), LSD post hoc tests were used to determine 
which dependent variable differed between methods. All protein targets 
yielded from the proteomics data from human muscle were compared 
between fractions using dependent samples t-tests. All data presented 
in figures and results are mean ± standard deviation (SD) values.
RESULTS
Protein yields in Experiment 1
BCA protein assays were performed in order to determine protein 
yields from each method in Experiment 1. Figure 1A demonstrates 
that similar amounts of rat gastrocnemius were used for each method 
which is critical given that different amounts of protein input between 
methods may skew results. MF protein concentrations from MF meth-
ods 2 and 3 were significantly greater than all other methods (Fig. 1B). 
The coefficient of variation (CV) values for triplicates from each assay 
were as follows: the Trizol method yielded a CV of 1.63%, the GCL 
method yielded a CV of 1.72%, MF method 1 yielded a CV of 16.52%, 
MF method 2 yielded a CV of 4.08%, and MF method 3 yielded a CV 
of 1.20%.
Only MF methods 1–3 yielded a sarcoplasmic protein fraction and, 
given that MF methods 1 and 2 have identical means of isolating the 
sarcoplasmic fraction, sarcoplasmic protein yield is only presented for 
MF methods 2 and 3. An independent samples t-test indicated that MF 
method 2 yielded more sarcoplasmic protein compared to MF method 3 
(P = 0.004; Fig. 1C).
Actin and myosin determination by Coomassie staining 
in Experiment 1
Performing SDS-PAGE and Coomassie staining of the MF fractions 
from each method enabled us to determine how much relative myosin 
heavy chain and actin were yielded given that these two proteins make 
up roughly 70% of the MF protein pool [22]. Coomassie staining results 
of the MF fractions from all five procedures are presented in Figure 2. 
The thick bands at 43 kD and 220 kD represent actin and myosin heavy 
chain, respectively. MF methods 1 and 2 yielded the densest bands at 
220 kD (Fig. 2A) and 43 kD (Fig. 2B) compared to the Trizol and GCL 
methods (P < 0.05) indicating that MF protein yield as well as fidelity 
was superior using the former two versus the latter two procedures. MF 
method 3 yielded a smear which is likely due to the addition of 0.3 M 
NaOH during MF pellet dissolution catalyzing alkaline-mediated hy-
drolysis. Notably, the Trizol method yielded very little protein overall.
Western blotting results for Experiment 1
While actin and myosin heavy chain bands were highly apparent 
using SDS-PAGE and Coomassie staining, we wanted to confirm their 
presence in different fractions using antibody-based detection via Western 
blotting. Notably, we elected not to analyze MF method 3 using this 
method given that hydrolysis of the MF fraction occurred (Fig. 2), and 
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we elected to analyze only MF method 2 rather than both MF methods 
1 and 2 given that the protein quantification results indicated more MF 
protein was yielded using spermidine addition (i.e., MF method 2).
MF method 2 yielded the greatest amount of myosin heavy chain 
and actin compared to the GCL and Trizol methods (Fig. 3A). Beyond 
determining which method yielded the greatest amounts of actin and 
myosin heavy chain in the MF fraction, we were also interested in de-
termining which method contained the greatest amount of MF protein 
contamination in the sarcoplasmic fraction. Given that MF methods 1 
and 2 have an identical initial procedure to yield sarcoplasmic protein, 
only the sarcoplasmic fraction from MF method 2 was analyzed. Further, 
MF method 3 was the only other technique that yielded a sarcoplasmic 
fraction and was also analyzed. MF methods 2 and 3 yielded sarcoplasmic 
fractions that contained trace amounts of myosin heavy chain, although 
the sarcoplasmic fraction of MF method 2 contained significantly more 
myosin heavy chain than the sarcoplasmic fraction of MF method 3 
(887 ± 297 density units vs. 118 ± 45 density units, P < 0.001; Fig. 3B). 
Both methods contained similar amounts of actin (MF method 2 = 409 
± 85 ADU, MF method 3 = 333 ± 62 ADU, P = 0.103; Fig. 3B).
Figure 1. Bicinchoninic acid assay results for rat tissue (Experiment 1). A. Muscle input weights for each method (six rats per method; specifically, 
three 6-month old and three 18-month old male Fisher rats). B. Total MF protein yield per method. C. SP protein yield per method. In (B), superscript 
letters that are different indicate significant differences between methods.
Figure 2. Coomassie staining results for rat tissue (Experiment 1). A. Coomassie band densities at 220 kD for all methods except MF method 3 (note 
that MF method 3 has band-smearing due to alkaline-mediated hydrolysis). B. Coomassie band densities at 43 kD for all methods except MF method 3. C. 
representative Coomassie staining gel for 3 rats (2 older and 1 younger); left to right orientation: MF isolate of MF method 2, MF isolate of MF method 1, 
sarcoplasmic protein, isolate from MF method 1&2, MF isolate of MF method 3, sarcoplasmic protein isolate from MF method 3, putative MF isolate of 
Trizol method, and putative MF isolate of GCL method. The letters “a” and “b” in (C) indicate myosin (220 kD) and actin (43 kD) bands, respectively with 
6 rats per method and specifically three 6-month old male Fisher rats and three 18-month old male Fisher rats. In (A) and (B), superscript letters that are 
different indicate significant differences between methods.
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Figure 3. Western blotting results for rat tissue (Experiment 1). A. Myosin and actin immunoblotting for MF protein isolates from MF method 2 as well 
as the GCL and Trizol methods (MF method 3 was not analyzed due to alkaline-mediated hydrolysis, and MF method 1 was not analyzed because MF 
method 2 was superior at yielding more MF protein). B. Myosin and actin immunoblotting for sarcoplasmic protein isolates from MF methods 2 and 3 to 
determine relative MF contamination (six rats per method; specifically, three 6-month old and three 18-month old male Fisher rats).
Experiment 2: an optimized approach for isolating 
myofibrillar and sarcoplasmic protein fractions from 
human muscle samples
Results from Figure 1-3 above clearly demonstrate that: MF method 2 
was best for yielding intact and solubilized MF protein, and buffer 1 from 
MF method 3 yielded sarcoplasmic proteins which were least contam-
inated by myosin heavy chain. Thus, Experiment 2 served to develop 
an optimized technique combining these two methods, and we elected 
to employ this method using six human muscle biopsy samples. Mus-
cle input weights and BCA assay results using this optimized protocol 
are presented in Figure 4A and 4B, and Figure 4C summarizes the 
compositional results when considering protein concentrations from 
each fraction.
We then wanted to use proteomics to validate our optimized approach. 
Performing proteomics on the sarcoplasmic and MF fraction enabled us to 
examine the top-enriched proteins in each fraction while also determining 
if these proteins contaminated the other fraction. The top dozen enriched 
proteins in the MF fraction from proteomic analysis are presented in 
Figure 4D. All of these proteins were contractile proteins and included 
myosin-2 (MYH2), myosin-1 (MYH1), myosin-7 (MYH7), myosin-4 
(MYH4), actin, alpha skeletal muscle (ACTS), actin, alpha cardiac 
muscle (ACTC), myosin-8 (MYH8), titin (TTN), myosin-3 (MYH3), 
alpha-actinin-2 (ACTN2), troponin T (TNNT), and troponin C (TNNC). 
Importantly, all of these proteins were significantly more enriched in 
the MF versus sarcoplasmic protein fraction (P < 0.01 for each target).
The top dozen enriched proteins in the sarcoplasmic fraction from 
proteomic analysis are presented in Figure 4E. All of these proteins 
were non-contractile proteins and included creatine kinase, m-type 
(CKM), myoglobin (MB), hemoglobin subunit-beta (HBB), enolase-3 
(ENO3), albumin (ALB), hemoglobin subunit alpha 1 (HBA1), ATPase 
sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 (ATP2A1), 
glycogen phosphorylase, muscle associated (PYGM), hemoglobin 
subunit, delta (HBD), pyruvate kinase (PKM), enolase-1 (ENO1), and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Importantly, all 
of these proteins were significantly more enriched in the sarcoplasmic 
versus MF protein fraction (P < 0.01 for each target).
DISCUSSION
Several proposed methods exist with the intent of isolating, solu-
bilizing, and quantifying MF proteins. These methods have included 
the Trizol method [14-16,32], MF method 1 [23], and MF method 3 
[18,24-26]. Herein, we sought to determine which of these methods 
best achieved MF protein isolation and solubilization using the three 
aforementioned methods along with a modified MF method 1 to im-
prove MF protein solubility (i.e., MF method 2) as well as a general cell 
lysis buffer method. Additionally, we sought to develop an optimized 
method for sarcoplasmic and myofibril isolation, and used proteomics 
to validate this method. A comparative summary outlining the pros and 
cons of each method from Experiments 1 and 2 is provided in Table 1.
Our results indicate that MF methods 2 and 3 should be utilized 
if the goal is to solubilize MF proteins and/or quantify total MF and 
sarcoplasmic protein concentrations. Additionally, MF method 2 can 
be used for downstream assays including Coomassie staining, Western 
blotting and proteomics, whereas MF method 3 is suitable for limited 
downstream assays (e.g., tracer analysis) given that protein hydrolysis 
of the MF fraction occurs. The only difference between MF methods 1 
and 2 is the addition of spermidine to the myofibril resuspension buffer 
(or buffer 3 described in the methods). Spermidine is a polyamine, and 
only one other paper to date has demonstrated that the addition of sper-
midine to a lysis buffer is capable of increasing protein solubility when 
processing plant tissues as well as animal Golgi-localized proteins [30]. 
These authors suggested this effect may be due to spermidine-mediated 
protein denaturation. Given that the MF protein pellet contains high 
molecular weight proteins which exist in a complex lattice network 
in vivo, we contend that spermidine acts to dissociate MF protein 
aggregates through denaturation. However, our Western blotting and 
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proteomic analyses demonstrated that spermidine does not hydrolyze 
proteins like what was observed in MF method 3 samples. Therefore, 
the addition to spermidine to buffer 3 in method 2 (as well as buffer 2 
in the optimized method) allows for the complete solubilization of MF 
proteins without the loss of these proteins through hydrolysis.
Table 1. Summary of experimental outcomes.
Method Pros Cons
GCL • Effective at isolating SP
• Can use for SP downstream assays (e.g., 
BCA, proteomics)
• Poor at isolating MF protein
Trizol • In relation to protein isolation, there are no pros • Poor at isolating MF or SP protein
• Per BCA assay results, technique likely overestimates 
protein yield given that Coomassie staining and Western 
blotting demonstrate virtually no protein is isolated
MF method 1 • Effective at isolating SP and MF protein
• Can use SP and MF protein for downstream 
analyses (e.g., Western blotting)
• While MF protein pellet is mostly solubilized, this 
technique does not completely solubilize the pellet; this 
limitation is evident with high between-sample and with-
in-sample duplicate variability in downstream assays
• Appears to be slight contamination of myosin in the SP 
protein fraction (Fig. 3B)
MF method 2 (addition of spermi-
dine to buffer 3 in MF method 1)
• Effective at isolating SP and MF protein
• Completely solubilizes MF protein
• Can use SP and MF protein for downstream 
analyses (e.g., Western blotting)
• Appears to be slight contamination of myosin in the SP 
protein fraction (Fig. 3B)
MF method 3 • Effective at isolating SP and MF protein
• Yields virtually no contamination of contractile 
proteins in the SP fraction
• Completely solubilizes MF protein
• Can use for tracer analysis, but cannot use for Western 
blotting or proteomics due to high NaOH content in buf-
fer 2 leading to alkaline-mediated protein hydrolysis
Optimized method (Experiment 2); 
recommended
• Effective at isolating SP and MF protein
• Completely solubilizes MF protein
• Yields virtually no contamination of contractile 
proteins in the SP fraction
• Can use SP and MF protein for downstream 
analyses (e.g., Western blotting or proteomics)
• No cons per the applications tested herein (Coomassie 
staining, Western blotting, proteomics)
Figure 4. Proteomic validation of optimized technique using human skeletal muscle (Experiment 2). Data are from 6 college-aged males using the 
MF and SP isolation techniques optimized from rodent experiments (Table 1 procedure). A. Muscle input weights. B. MF and SP protein concentrations. 
C. Estimated muscle constituents per data in (A) and (B). D. The top 12 enriched proteins (mean ± SD) in the MF fraction (gray bars), showing negligible 
contamination in the sarcoplasmic fraction (white bars); E. The top 12 enriched proteins (mean ± SD) in the sarcoplasmic fraction (white bars), showing 
negligible contamination in the MF fraction (gray bars).
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While BCA analysis indicated that all methods yielded protein, 
Coomassie staining and Western blotting demonstrated that the Trizol 
and GCL methods poorly isolate MF proteins. These results are likely 
due to much of the MF fraction being poorly soluble in the GCL and 
1.0% SDS buffers, respectively. In fact, both methods visually left large 
protein pellets following the final centrifugation steps, and these pellets 
were likely MF proteins. Further, it has been previously reported that 
the Trizol method poorly solubilizes proteins [33,34]. Thus, significant 
errors in the MF protein concentrations may affect the conclusions of 
prior studies which have used this method.
Homogenizing muscle with buffer 1 of MF method 3 yielded a 
sarcoplasmic fraction that contained significantly less myosin relative 
to homogenizing buffer 1 of MF method 2. This may be the reason 
why MF method 3 yielded numerically greater MF protein concen-
trations and significantly less sarcoplasmic protein compared to MF 
method 2 (Fig. 1B and 1C). Our optimized procedure performed on 
human muscle samples (Experiment 2), which we have coined to be 
the “myofibril isolation and solubilization technique” or “MIST” and 
involved combining MF methods 2 and 3, seemingly optimized the 
yield and integrity of the sarcoplasmic and MF fractions; this procedure 
is summarized in Table 2. Proteomics indicated that this procedure 
yielded lowly-contaminated sarcoplasmic and MF fractions as well as 
a solubilized MF fraction suitable for downstream assays. Specifically, 
the top 12 enriched proteins in the MF and sarcoplasmic isolates were 
contractile and metabolic proteins, respectively, which would be ex-
pected to found in this fraction per the commentary of Haun et al. [22].
Table 2. The “MIST” method from Experiment 2 for myofibrillar and sarcoplasmic protein isolation.
Step General notes Buffer recipe
1 Obtain 10–50 mg of powdered muscle on a LN2-cooled stage, and place in a 1.7 ml microtube (Tube 1) on 
a pre-tared analytical scale; weigh tissue for standardizing protein results
N/Aa
2 Place Tube 1 with muscle on ice and add 10 volumes (100–500 µl) of ice cold buffer 1 Buffer 1: 25 mM Tris, pH 7.2, 
0.5% Triton X-100
3 Use a tight-fitting microtube pestle to homogenize sample into a slurry, and place Tube 1 back on ice until 
all samples are homogenized
N/Aa
4 Centrifuge Tube 1 at 1500 g for 10 min at 4°C N/Aa
5 Pipet off supernatant (sarcoplasmic fraction) and place into a new 1.7 ml microtube (Tube 2), but leave 
~10 µl of supernatant on top of protein pellet in order to reduce sarcoplasmic contamination with MF pro-
tein or loss of MF protein; store Tube 2 at −80°C for downstream assays
N/Aa
6 Resuspend protein pellet in Tube 1 with 10 volumes (100–500 µl) of ice cold Buffer 1 as a wash step N/Aa
7 Centrifuge tubes at 1500 g for 10 min at 4°C N/Aa
8 Pipet off supernatant, but leave ~10 µl on top of protein pellet in order to reduce loss of MF protein; allow 
pellets to dry on ice, or use a fine-tip pipettor (e.g., Western blotting loading tip) to remove the remainder 
of the wash buffer in order to prevent disrupting the MF pellet
N/Aa
9 Add 15 volumes of ice cold buffer 2 to pellet in Tube 1, and resuspend using a tight-fitting pestle; remain-
ing/un-suspended protein is putatively collagen
Buffer 2: 20 mM Tris-HCl, pH 
7.2, 100 mM KCl, 20% glycerol, 
1 mM DTT, 50 mM spermidine
10 Perform a quick-spin on a desktop centrifuge for 1 min, and transfer supernatant (MF fraction) to a new 
tube (Tube 3)
N/Aa
Notes: • Through extensive experimentation, we recommend performing BCA assays for the sarcoplasmic and MF fractions in triplicate using 1:5 
diluted samples
• With our experience with the BCA assay, buffers 1 and 2 have minimal impact on absorbance readings; we have not attempted other 
protein assays (e.g., Bradford or Fluorescamine)
• When possible, attempt to standardize the amount of tissue input from all samples (e.g., 20 mg)
• To obtain muscle protein concentrations following the BCA assay, implement the following equations below:
• Sarcoplasmic protein concentration (µg/mg wet tissue) = ([BCA result in µg/µl] × dilution factor × volume used in Step 2 (µl)) / mg muscle 
used
• MF protein concentration (µg/mg wet tissue) = ([BCA result in µg/µl] × dilution factor × volume used in Step 9 (µl)) / mg muscle used
aN/A: Not available. Other note: can add 20 volumes (i.e., 400 µl per 20 mg tissue) of buffer 2 to MF pellet to improve solubility.
In conclusion, the intent of this methodological study is to provide 
guidance for researchers aiming to examine longer-term changes in 
MF protein concentrations from human and rodent skeletal muscle. 
While numerous methods on this technique have been published, the 
standardization of this technique using optimized methods outlined 
herein can ultimately provide more congruent findings in the literature.
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